Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evinacumab in severe hypertriglyceridemia
NCT03452228Phase 2Completed
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Jun 2018
- Primary completion
- Dec 2019
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of evinacumab in hypertriglyceridemia, sponsored by Regeneron Pharmaceuticals. Started Jun 2018; status: completed.
02
Drugs
evinacumab
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT03452228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03452228.